Precision Wealth Strategies, LLC Intellia Therapeutics, Inc. Transaction History

Precision Wealth Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$38.49 - $76.21 $468,577 - $927,780	-12,174 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$58.27 - $118.99 $156,979 - $320,559	2,694 Added 28.42%	12,174 $885,000
Q4 2021 Jan 19, 2022	BUY	$100.76 - $138.36 $3,728 - $5,119	37 Added 0.39%	9,480 $1.12 Million
Q3 2021 Nov 02, 2021	BUY	$132.37 - $176.78 $191,936 - $256,331	1,450 Added 18.14%	9,443 $1.27 Million
Q2 2021 Jul 22, 2021	BUY	$60.88 - $161.91 $35,614 - $94,717	585 Added 7.9%	7,993 $1.29 Million
Q1 2021 Apr 26, 2021	BUY	$46.59 - $83.68 $66,483 - $119,411	1,427 Added 23.86%	7,408 $595,000
Q4 2020 Apr 26, 2021	BUY	$18.83 - $63.53 $112,622 - $379,972	5,981 New	5,981 $325,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.05B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Precision Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Precision Wealth Strategies, LLC with notifications on news.